These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 27659733)
1. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. Steegen K; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; Variava E; MacLeod W; Sanne I; Stevens WS; Carmona S J Antimicrob Chemother; 2017 Jan; 72(1):210-219. PubMed ID: 27659733 [TBL] [Abstract][Full Text] [Related]
2. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy. Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463 [TBL] [Abstract][Full Text] [Related]
3. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies. Hamers RL; Sigaloff KC; Wensing AM; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Stevens WS; Rinke de Wit TF; Schuurman R; Clin Infect Dis; 2012 Jun; 54(11):1660-9. PubMed ID: 22474222 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa. Skhosana L; Steegen K; Bronze M; Lukhwareni A; Letsoalo E; Papathanasopoulos MA; Carmona SC; Stevens WS PLoS One; 2015; 10(2):e0118145. PubMed ID: 25659108 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study. Loubet P; Charpentier C; Visseaux B; Borbor A; Nuta C; Adu E; Chapplain JM; Baysah M; Tattevin P; Yazdanpanah Y; Descamps D J Antimicrob Chemother; 2015; 70(6):1881-4. PubMed ID: 25698771 [TBL] [Abstract][Full Text] [Related]
6. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa. Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647 [TBL] [Abstract][Full Text] [Related]
7. High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali. Fofana DB; Soulié C; Baldé A; Lambert-Niclot S; Sylla M; Ait-Arkoub Z; Diallo F; Sangaré B; Cissé M; Maïga IA; Fourati S; Koita O; Calvez V; Marcelin AG; Maïga AI J Antimicrob Chemother; 2014 Sep; 69(9):2531-5. PubMed ID: 24855120 [TBL] [Abstract][Full Text] [Related]
8. Short communication: east meets west: a description of HIV-1 drug resistance mutation patterns of patients failing first line therapy in PEPFAR clinics from Uganda and Nigeria. Crawford KW; Wakabi S; Kibuuka H; Magala F; Keshinro B; Okoye I; Akintunde E; Hamm TE AIDS Res Hum Retroviruses; 2014 Aug; 30(8):796-9. PubMed ID: 24798614 [TBL] [Abstract][Full Text] [Related]
9. Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy. Etiebet MA; Shepherd J; Nowak RG; Charurat M; Chang H; Ajayi S; Elegba O; Ndembi N; Abimiku A; Carr JK; Eyzaguirre LM; Blattner WA AIDS; 2013 Feb; 27(4):553-61. PubMed ID: 23079810 [TBL] [Abstract][Full Text] [Related]
10. Genotypic HIV-1 Drug Resistance Among Patients Failing Tenofovir-Based First-Line HAART in South India. Dinesha TR; Gomathi S; Boobalan J; Sivamalar S; Solomon SS; Pradeep A; Poongulali S; Solomon S; Balakrishnan P; Saravanan S AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1234-1236. PubMed ID: 27334566 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana. Diphoko T; Gaseitsiwe S; Kasvosve I; Moyo S; Okatch H; Musonda R; Wainberg M; Makhema J; Marlink R; Novitsky V; Essex M AIDS Res Hum Retroviruses; 2018 Aug; 34(8):667-671. PubMed ID: 29732907 [TBL] [Abstract][Full Text] [Related]
12. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa. van Zyl GU; van der Merwe L; Claassen M; Zeier M; Preiser W J Med Virol; 2011 Oct; 83(10):1764-9. PubMed ID: 21837793 [TBL] [Abstract][Full Text] [Related]
14. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines. Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571 [TBL] [Abstract][Full Text] [Related]
15. Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy--implications for sustained efficacy of ART in resource-limited settings. Hill A; McBride A; Sawyer AW; Clumeck N; Gupta RK J Infect Dis; 2013 Jun; 207 Suppl 2():S78-84. PubMed ID: 23687293 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia. Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970 [TBL] [Abstract][Full Text] [Related]
17. Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda. Ayitewala A; Kyeyune F; Ainembabazi P; Nabulime E; Kato CD; Nankya I AIDS Res Ther; 2020 Jan; 17(1):2. PubMed ID: 32005262 [TBL] [Abstract][Full Text] [Related]
18. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa. Manasa J; Lessells RJ; Skingsley A; Naidu KK; Newell ML; McGrath N; de Oliveira T; PLoS One; 2013; 8(8):e72152. PubMed ID: 23991055 [TBL] [Abstract][Full Text] [Related]
19. Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon. Aghokeng AF; Kouanfack C; Eymard-Duvernay S; Butel C; Edoul GE; Laurent C; Koulla-Shiro S; Delaporte E; Mpoudi-Ngole E; Peeters M J Int AIDS Soc; 2013 Jan; 16(1):18004. PubMed ID: 23374858 [TBL] [Abstract][Full Text] [Related]
20. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey. Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]